Abcellera Biologics Stock Price on November 29, 2024
| ABCL Stock | USD 3.00 0.17 6.01% |
If you're considering investing in Abcellera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Abcellera Biologics stands at 3.00, as last reported on the 29th of November, with the highest price reaching 3.07 and the lowest price hitting 2.87 during the day. Abcellera Biologics appears to be very risky, given 3 months investment horizon. Abcellera Biologics secures Sharpe Ratio (or Efficiency) of 0.0924, which signifies that the company had a 0.0924% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Abcellera Biologics, which you can use to evaluate the volatility of the firm. Please makes use of Abcellera Biologics' mean deviation of 2.87, and Risk Adjusted Performance of 0.064 to double-check if our risk estimates are consistent with your expectations.
At this time, Abcellera Biologics' Common Stock Shares Outstanding is quite stable compared to the past year. Other Stockholder Equity is expected to rise to about 127.1 M this year, although the value of Common Stock Total Equity will most likely fall to about 479 M. . The value of Price To Sales Ratio is estimated to slide to 41.25. Price Earnings Ratio is expected to rise to -10.71 this year. Abcellera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Abcellera |
Sharpe Ratio = 0.0924
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABCL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.93 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Abcellera Biologics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abcellera Biologics by adding it to a well-diversified portfolio.
Price Book 0.8219 | Enterprise Value Ebitda 5.3008 | Price Sales 26.8824 | Shares Float 189 M | Wall Street Target Price 12.2857 |
Abcellera Biologics Valuation on November 29, 2024
It is possible to determine the worth of Abcellera Biologics on a given historical date. On November 29, 2024 Abcellera was worth 2.88 at the beginning of the trading date compared to the closed value of 3.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Abcellera Biologics stock. Still, in general, we apply an absolute valuation method to find Abcellera Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abcellera Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Abcellera Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 2.88 | 3.07 | 2.87 | 3.00 | 4,282,500 | |
11/29/2024 | 2.88 | 3.07 | 2.87 | 3.00 | 0.00 |
| Backtest Abcellera Biologics | | | Abcellera Biologics History | | | Abcellera Biologics Valuation | Previous |
Abcellera Biologics Trading Date Momentum on November 29, 2024
| On November 29 2024 Abcellera Biologics was traded for 3.00 at the closing time. The top price for the day was 3.07 and the lowest listed price was 2.87 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.00% . |
Abcellera Biologics Fundamentals Correlations and Trends
By evaluating Abcellera Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Abcellera Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Abcellera financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Abcellera Biologics Stock history
Abcellera Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abcellera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abcellera Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abcellera Biologics stock prices may prove useful in developing a viable investing in Abcellera Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 289.2 M | 290.3 M | |
| Net Income Applicable To Common Shares | 182.3 M | 94.4 M |
Abcellera Biologics Quarterly Net Working Capital |
|
Abcellera Biologics Stock Technical Analysis
Abcellera Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Abcellera Biologics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Abcellera Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Abcellera Biologics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Abcellera Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Abcellera Biologics shares will generate the highest return on investment. By undertsting and applying Abcellera Biologics stock market strength indicators, traders can identify Abcellera Biologics entry and exit signals to maximize returns
Abcellera Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Abcellera Biologics' price direction in advance. Along with the technical and fundamental analysis of Abcellera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abcellera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.064 | |||
| Jensen Alpha | 0.1458 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0504 | |||
| Treynor Ratio | 0.2479 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.61) | Revenue Per Share 0.112 | Quarterly Revenue Growth (0.01) | Return On Assets (0.13) |
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.